Blood Res 2017; 52(2): 145-148  https://doi.org/10.5045/br.2017.52.2.145
The first case of paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome treated with complement inhibitor eculizumab in Korea
Hyerim Kim1, In-Suk Kim2*, Su-Hee Cho3, Hyun Ji Lee2, Chulhun L Chang2, and Ki Tae Yoon4

1Department of Laboratory Medicine, Pusan National University School of Medicine and Biomedical Research Institute Research Institute, Pusan National University Hospital, Busan, Korea.

2Department of Laboratory Medicine, Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Yangsan, Korea.

3Division of Hematology-Oncology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.

4Division of Gastroenterology and Hepatology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.

Correspondence to: In-Suk Kim. Department of Laboratory Medicine, Pusan National University Yangsan Hospital, 20, Geumo-ro, Mulgeum-eup, Yangsan 50612, Korea. iskim0710@gmail.com
Received: August 10, 2016; Revised: October 25, 2016; Accepted: January 3, 2017; Published online: June 22, 2017.
© The Korean Journal of Hematology. All rights reserved.



e-submission

This Article

Current Issue

ba_link01

Indexed/Covered by

Today : 75  /
Total : 138,987